Simon Allen
Fine Treatment, UK
Keynote: J Nephrol Ther
Thermobalancing therapy?® (TT) and Dr. Allenâ??s therapeutic devices (DATD) provide a side effects free treatment for common chronic urological diseases, such as benign prostatic hyperplasia (BPH), chronic prostatitis and kidney stone disease. TT and DATD received US patent as â??Therapeutic Device and Methodâ?. TT is based on a new understanding of the origin of diseases that states that all chronic internal diseases have the same root, the pathological activity of capillaries. As a result of changes in small blood vessels, the focus of hypothermia becomes a continuous trigger in the affected tissue, which gradually increases the pressure in the affected organ that leads to its malfunction. Therapeutic device applies a natural thermoelement, which accumulates the body heat, to the projection of the affected organ eliminating the focus of hypothermia. For prostate problems, thermoelement must be applied to the coccyx area and to dissolve kidney stones 2 thermoelements must be applied to the projection of kidneys. Dr. Allenâ??s device is a class 1 medical device, so it can be used by everyone at home. Two clinical trials on TT confirmed its effectiveness. After six-month use of DATD in 124 men with BPH, the prostate volume (mL) decreased from 45.1 to 31.8 and urinary symptoms score from 14.3 to 4.7. In men with chronic prostatitis, after six-month use of DATD pain reduction ranged from 10.3 to 3.5, and prostate volume (mL) from 31.7 to 27.0. There were no changes in the control groups. Thus, TT is an effective tool for urological conditions.
Simon Allen obtained his PhD in Medicine in 1978. For many years he was treating patients with chronic internal diseases, including various kidney problems: nephritis, nephrosis, chronic kidney failure and kidney stones, developing diets for them. Later he headed Health Clinic for the treatment of chronic internal conditions. Then, he devoted two decades to further medical research and developed Thermobalancing therapy® and Dr. Allen’s devices for chronic internal diseases, which received a patent in the USA, as “Therapeutic Device and Method”. He is Director of Fine Treatment, United Kingdom, which distributes these devices worldwide.
Email:finetreatment@gmail.com
Journal of Nephrology & Therapeutics received 784 citations as per Google Scholar report